David Pyott
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Pyott
Earlier roles on record: Board Member at Pliant Therapeutics, Inc. (PLRX) until April 17, 2026. Pliant Therapeutics, Inc. reported in an 8-K filed April 17, 2026 that David Pyott retired as Class I director on the Board of Directors.
“On April 14, 2026, David E.I. Pyott, a Class I director on the Board of Directors (the "Board") of Pliant Therapeutics, Inc. (the "Company") and a member of the Audit Committee and the Nominating and Corporate Governance Committee of the Board, notified the Chief Executive Officer of the Company, Chairman of the Board, and Chair of the Nominating and Corporate Governance Committee of his retirement from the Board and all committees thereof, effective as of the Company's 2026 Annual Meeting of Stockholders (the "Annual Meeting").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2026-04-17
-
2021-01-01–2026-04-17
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.